Affiliation:
1. Malaria and Vector Research Group, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
Abstract
Plasmodium falciparum
cell-traversal protein for ookinetes and sporozoites (PfCelTOS) is an advanced vaccine candidate that has a crucial role in the traversal of the malaria parasite in both mosquito and mammalian hosts. As recombinant purified proteins are normally poor immunogens, they require to be admixed with an adjuvant(s); therefore, the objective of the present study was to evaluate the capacity of different vaccine adjuvants, monophosphoryl lipid A (MPL), CpG, and
Quillaja saponaria
Molina fraction 21 (QS-21), alone or in combination (MCQ [MPL/CpG/QS-21]), to enhance the immunogenicity of
Escherichia coli
-expressed PfCelTOS in BALB/c mice.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference81 articles.
1. World Trade Report 2017
2. World Health Organization. 2012. Global plan for insecticide resistance management in malaria vectors. World Health Organization, Geneva, Switzerland. https://www.who.int/malaria/publications/atoz/gpirm/en/.
3. Artemisinin resistance: current status and scenarios for containment
4. Control to elimination: implications for malaria research
5. A Research Agenda for Malaria Eradication: Vaccines
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The effect of carbohydrate adjuvants in the composition of the experimental hantavirus vaccine on the dynamics of neutralizing antibodies in the blood sera of guinea pigs;Journal of microbiology, epidemiology and immunobiology;2024-07-16
2. Malaria transmission blocking activity of Anopheles stephensi alanyl aminopeptidase N antigen formulated with MPL, CpG, and QS21 adjuvants;PLOS ONE;2024-07-05
3. GD2-targeting therapy: a comparative analysis of approaches and promising directions;Frontiers in Immunology;2024-03-15
4. Evaluation of a new fusion antigen, cd loop and HAP2-GCS1 domain (cd-HAP) of Plasmodium falciparum Generative Cell Specific 1 antigen formulated with various adjuvants, as a transmission blocking vaccine;Malaria Journal;2023-12-09
5. CRISPR/Cas advancements for genome editing, diagnosis, therapeutics, and vaccine development for Plasmodium parasites, and genetic engineering of Anopheles mosquito vector;Infection, Genetics and Evolution;2023-04